Next Article in Journal
Comparative Performance of Eight PCR Methods to Detect Cryptosporidium Species
Next Article in Special Issue
Genome-Wide Association Analysis for Triazole Resistance in Aspergillus fumigatus
Previous Article in Journal
Geographical Variation in Coxiella burnetii Seroprevalence in Dairy Farms Located in South-Western Ethiopia: Understanding the Broader Community Risk
Previous Article in Special Issue
Allergic Bronchopulmonary Aspergillosis in Children with Cystic Fibrosis: An Update on the Newest Diagnostic Tools and Therapeutic Approaches
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Aspergillus Genus and Its Various Human Superficial and Cutaneous Features

1
Department Parasitology-Mycology, ‘Hassani Abdelkader’ Hospital, UDL Faculty of Medicine, Laboratoire de Synthèse de L’information Environementale, UDL, Sidi-Bel-Abbes 22000, Algeria
2
Department of Pulmonary Diseases, ‘Hassani Abdelkader’ Hospital, UDL Faculty of Medicine, Sidi-Bel-Abbes 22000, Algeria
3
Department of Environmental Sciences, Faculty of Natural Science and Life, University Djilali Liabes, Sidi-Bel-Abbes 22000, Algeria
4
Department of Hemobiology and Blood Transfusion, ‘Hassani Abdelkader’ Hospital, UDL Faculty of Medecine, Sidi-Bel-Abbes 22000, Algeria
*
Author to whom correspondence should be addressed.
Pathogens 2021, 10(6), 643; https://doi.org/10.3390/pathogens10060643
Submission received: 2 February 2021 / Revised: 9 May 2021 / Accepted: 13 May 2021 / Published: 23 May 2021
(This article belongs to the Special Issue Aspergillosis)

Abstract

:
Superficial and cutaneous aspergillosis is a rare fungal disease that is restricted to the outer layers of the skin, nails, and the outer auditory canal, infrequently invading the deeper tissue and viscera, particularly in immunocompromised patients. These mycoses are acquired through two main routes: direct traumatic inoculation or inhalation of airborne fungal spores into paranasal sinuses and lungs. Lesions are classified into three categories: otomycosis, onychomycosis, and cutaneous aspergillosis. Superficial and cutaneous aspergillosis occurs less frequently and therefore remains poorly characterized; it usually involves sites of superficial trauma—namely, at or near intravenous entry catheter site, at the point of traumatic inoculation (orthopaedic inoculation, ear-self-cleaning, schizophrenic ear self-injuries), at surgery incision, and at the site of contact with occlusive dressings, especially in burn patients. Onychomycosis and otomycosis are more seen in immunocompetent patients, while cutaneous aspergillosis is widely described among the immunocompromised individuals. This paper is a review of related literature.

1. Introduction

Aspergillus species are a large group of common saprophytic moulds which are isolated from soil, air, and plant materials. Aspergillus species can cause a group of superficial and cutaneous mycoses: distal lateral subungual onychomycosis, proximal subungual onychomycosis, otomycosis, and cutaneous aspergillosis [1,2].
Almost all Aspergillus skin infections are nosocomially acquired, particularly in newborn or immunocompromised patients or following medical procedures such as surgery, catheter insertion, or after occlusive dressings in burn patients [3,4,5]. On the other hand, cutaneous trauma and injuries are also the main risk factors of Aspergillus superficial and cutaneous features [6,7,8].
Lesions are commonly solitary and typically develop on the catheter site of insertion, wound dressing, and sites of trauma. The lesions arise as papules, nodules, or ulcerations, or they can mimic dermatophytosis [2,9].

2. Source of Infection

The initial step of aspergillosis is colonization of the sites, such as the auditory canal, wounds, injuries, and fragile nails. The origin of infection may be conidia of the fungus from the surrounding air that fell and contaminated a wound [10]; conidia can also be inoculated into skin after injury or surgical procedures.
Aspergillus airborne organisms may be introduced into the body (ear, wound, skin) by an object or following a post-operative procedure; otomycosis may also be considered as a super-infection following a bacterial otitis [11,12,13,14].

3. Risk Factors

3.1. Environmental Factors

3.1.1. Outdoor Conditions

Aspergillus species are ubiquitous environmental moulds present in air, soil, water, and decaying vegetation [10,15,16]. Beany and Broughton have attributed the greater frequency of otomycosis in the tropical countries to changes in the composition of cerumen induced by sweating; furthermore, seasonal variations that have been reported in the incidence of filamentous fungal mycosis have been related to many environmental factors, such humidity, wind, and rainfall and have been also linked to the harvest [16,17,18].

3.1.2. Hospital Conditions

Because catheter insertions and surgeries are typically done in hospital, almost all skin aspergilloses are hospital-acquired infections; moreover, umbilical catheter infection by Aspergillus species have been reported in newborns, and Aspergillus wound infection is recognized among burn patients treated in hospital [3,4,6].
Malfunctions in healthcare facility systems, improper installation, filter damage, and poor maintenance can facilitate the spread of healthcare–associated airborne infections [19].

3.2. Host Factor

The outcome of aspergillosis depends more on host factors than on the virulence of the Aspergillus species [20,21,22] (Figure 1).
Onychomycosis is more common in the elderly [23,24,25]. Premature infants and newborns are at increased risk of developing superficial and cutaneous aspergillosis; it is widely maintained that the immature immune system of the preterm infant, along with vulnerable skin barrier function, are major factors for superficial and cutaneous aspergillosis [26,27,28,29].
Poor hygiene, barefoot walking, sweating, and paronychia predispose to onychomycosis; moreover, occupational exposure such as household chores and gardening can provoke aspergillosis [18], which is more common in immunosuppressed patients [23,24,25].

3.2.1. Physical Activities and Occupational Exposure

Onychomycosis, induced by Aspergillus genus, occurs more commonly than realized, especially in outdoor workers and in agricultural communities [12]. Several patients reported dystrophic nail abnormalities or nail trauma prior to the onset of the mould onychomycosis [30].
Onychomycosis is associated with barefoot walking, and paronychia predispose to onychomycosis, especially in sport activities (athlete’s foot) [18]. Aspergillus onychomycosis is seen more among individuals with occupational exposure, as described among vegetable vendors and babassu coconut breakers [31,32,33] and among patients after exposures such as gardening or household chores [18]. Many reports have depicted primary infection in immunocompetent patient in association with previous agricultural trauma [34].
Otomycosis caused by filamentous fungi is usually seen among communities of fisherman [17]. Swimming and other water activities are important because many people swim and dive. Sometimes the external auditory canal is directly exposed to water without any protection [17,35,36].

3.2.2. Local Humidity and Skin Maceration

Various factors have been suggested as predisposing factors for otomycosis, including swimming regularly and living in a humid environment [17]. One of the contributing factors to this condition is the removal of the protective coating of cerumen by repeated washing and cleaning of the ear canal. Moreover, the right diagnosis and treatment of otomycosis needs a high degree of suspicion in refractory cases of otorrhea; it is clear that both trauma and excessive moisture impair the ear’s natural defences [17,37]. High humidity provides satisfactory conditions for fungal growth [38]. Kim et al. described a case of Aspergillus onychomycosis: the patient used to plant beans and therefore her hands were generally exposed to water for long periods of time. Thus, occupation seems be closely linked to the disease’s development [30], especially when one is in continuing contact with water, detergents, and chemical products.
Furthermore, some religious, cultural, or aesthetical practices leave the external ear canal wet (ablutions, wearing a scarf or veil) [39], which may predispose people to otomycosis induced by Aspergillus genus.

3.2.3. Trauma Exposure

Aspergillus conidia can develop and grow on damaged skin. Usually, patients have been exposed to several kind of trauma.

Ear Trauma

Some traumas are induced by the patient’s habits, such as ear self-cleaning leading to otomycosis. Moreover, self-inducted injuries are already described in schizophrenia, and Aspergillus flavus otomycosis has been linked to ear self-mutilation [7].

Nail Trauma

Athlete’s foot is induced by regular sport activities, which is well described in literature [23,30]; even the habit of wearing tight shoes can induce toenails onychomycosis [40].

Skin Trauma

Primary cutaneous aspergillosis has been related to agricultural trauma, orthopaedic trauma [1,34], or traffic injuries [41]; usually, the symptoms appear within one month of injury [41].
Panke et al. [42] observed a “fruiting bodies” of Aspergillus on the skin of a burned patient. Furthermore, burn wounds can be infected by Aspergillus genus [6,43,44].
A primary cutaneous aspergillosis may act as a source of fungal dissemination to various organs of the body, including the lungs, the heart, and the central nervous system [13].
Septic shock caused by Aspergillus fumigatus infection was reported in a patient with a lacerated lower limb after being injured in a factory blast; the cause of septic shock was the existence of the fungi within the wound [45].
A 31-year-old healthy female presented with multiple axillary and perineal ulcers following incision and drainage of slowly growing nodular lesions over a one-year duration. She admitted to shaving her axillae and pubic region with a safety razor several times during the one-year period. Culture and histology revealed a significant growth of Aspergillus [8].
Some of the Aspergillus infections induced by trauma are summarized in Table 1.

3.2.4. Underlying Medical Conditions

Usually, aspergillosis starts from a lung infection subsequent to inhalation of airborne spores. Moreover, in the immunocompromised patient, hematogenous dissemination and invasion of other organ systems, including skin, often follows primary pulmonary infection. Cutaneous aspergillosis can be considered as a cutaneous manifestation of disseminated infection with the Aspergillus species.
Primary cutaneous aspergillosis was previously described in immunocompromised patients [49,50], especially in HIV patients [2,4,48,49,50,51,52].
Shetty et al. [4] described a cutaneous non-healing ulcer on the right calf muscle of an HIV infected child, with no wound dressing and no previous trauma. The skin biopsy specimen revealed hyphal elements, and the culture of the sample grew Aspergillus glaucus.
Several reports have described primary or secondary cutaneous aspergillosis in immunocompromised patients who are not infected with HIV, including burn victims, neonates, cancer patients, solid-organ and bone marrow transplant recipients [53,54,55,56,57,58,59].
Diabetes mellitus and hyperglycaemia from hyper-alimentation are additional risk factors in burn patients [51]. Diabetic burn patients seem to have a higher rate of infection in comparison with non-diabetic burn patients [60].
In a literature review, Aspergillus niger skin infection following bone marrow transplant was also described [58], as well as cutaneous aspergillosis following kidney transplant [60,61]. Moreover, multiple A. fumigatus inflammatory nodules of the lower limb were reported after a liver transplant [12].
Furthermore, unique painful, necrotic nodule of the calf muscle, toe paronychia, and catheter site necrosis were induced by Aspergillus flavus in leukaemia patients [12], and invasive aspergillosis can occur in the course of cutaneous aspergillosis-associated with acute myeloid leukaemia [62].
On the other hand, diabetes mellitus has not been identified as a risk factor for invasive aspergillosis in the general population. However, in the Aspergillus infections literature, the proportion of patients with diabetes mellitus tended to be high [63]. Diabetes mellitus has also been present in relation with Aspergillus nails infections. The latter is an emerging onychomycosis pathogen among diabetics, and the risk of having Aspergillus nail disorders among patients being treated for diabetes increases with the duration of the disease [64]. In a study conducted in India among patients who were involved in agricultural activities, 77% were diabetic and were confirmed to have Aspergillus onychomycosis [64]. Nail damage can be noticed in HIV patients and in patients with hormonal imbalance induced by Cushing’s syndrome and hypothyroidism.
Some additional underlying diseases have been associated with cutaneous aspergillosis; they are summarized in Table 2.

3.2.5. Medical Procedures

Different medical procedures are related to superficial and cutaneous Aspergillus infections, such as exploratory medical procedures, medical treatments, and surgery.
Smith and Wallace reported a cutaneous lesion of a patient under radiation therapy for non-Hodgkin’s lymphoma; the lesion was located under the dressing of a venous catheter, and histopathology revealed numerous branching hyphae within the follicular infundibulum [69]. Total parenteral nutrition in burn patients is a risk factor of fungal infection [51,70].

Medical Devices

Predisposing factors of Aspergillus otomycosis include the use of hearing aids with occlusive ear mould that may provoke accumulation of cerumen and epithelial debris in the external auditory canal [71]. The catheters are widely used, and they can be the most common source of Aspergillus infection.

Insertion of Catheters

Many of the cutaneous aspergillosis infections in the early 1980s and 1990s were related to Hickman catheters [2,48]. The initial mechanism of aspergillosis involves making a tunnel through the skin, allowing for a direct inoculation of fungi [2,46,49]. In cutaneous Aspergillosis, the lesions usually develop at the site of catheterization [72]; they can be erythematous and indurated [48].
Greenish lesions in the umbilical region of two preterm twins were described. The catheters were removed, and the culture was positive for Aspergillus fumigatus [73]. Central catheters are currently used in burn patients, especially in severe cases with prolonged IUC stay [70].

Applying Bandages, Dressings and Gauze

In some cutaneous Aspergillosis, the lesions are generally located at points of contact with gauze or dressings [26]. Smith and Wallace reported a cutaneous lesion under the transparent dressing of a venous catheter [69].
Bandages may be a source of infection [72]. Burn wound dressings are carried out by either the open or occlusive method. Open dressings are associated with a higher incidence of infection than occlusive dressings [10], as are those with extensive burns (>50%).
Recently, primary cutaneous aspergillosis with Aspergillus niger at the place of skin abrasion that had been managed by a cyanoacrylate topical skin adhesive was described [74].

Medical Instrumentation

In otomycosis, predisposing factors include ear medical instrumentation [14,71]. Ozer et al. described a case of cutaneous infection caused by Aspergillus terreus in a paediatric patient who underwent surgical treatment for an open tibial fracture [34].
Anderson et al. reported an ear surgical wound healing that was complicated by Aspergillus flavus infection in a non-immunocompromised patient.
Primary cutaneous aspergillosis can occur directly in the surgical wound among liver or renal transplantation patients [13,61,66].

Medical Drugs

Fungal infections are a well-known complication of broad-spectrum antibacterial use. Furthermore, otitis may be exacerbated by the prescription of broad-spectrum antibiotics such as fluoroquinolone eardrops [75].
Currently, mixed bacterial and fungal otitis are the consequence of long courses of bacterial otitis treatment, leading to the alteration of the normal ear flora [14].
Corticosteroids significantly impair the functionality of innate immunity, and steroid-induced hyperglycaemia might further weaken the innate immune response against mould infections such as Aspergillosis [63,70].
Agranulocytosis treated with antithymocyte globulin was related to skin aspergillosis [50,51]
Prolonged hospital stay and the use of broad spectrum antibiotics were related to cutaneous Aspergillus in burn patients [10], and the incidence may have risen due to the suppression of bacterial infections with use of silver sulphadiazine and prompt surgical excision [70].

4. Cutaneous and Superficial Aspergillosis

4.1. Otomycosis

Otomycosis is a fungal superficial, subacute or chronic infection of the external auditory canal with some rare invasive complications involving the middle and inner ear. Pruritus is the most common fungal symptom of otomycosis [38]. Rarely, otomycosis can spread to nearby structures, such as eardrum, bone, and cartilage, particularly in immunocompromised patients, and especially by Aspergillus species [76]. In addition, Aspergillus niger was seen in chronic unilateral otomycosis and invasive otitis externa [77]. Aspergillus otomycosis is relatively frequent. Mycological study of otomycosis in the eastern part of Maharashtra (India) revealed 25% of Aspergillus cases [78].
Predisposing factors include living in a humid climate, moisture, bathing, the presence of excessive cerumen, wearing turbans, repeated use of topical antibiotics and steroids or ear oil instillation [17,35,36], medical instrumentation, self-cleaning of the ear with foreign or unsterilized objects, and ear auto-mutilation in schizophrenia (Figure 2). Furthermore, Aspergillus otomycosis can be seen in immunocompromised hosts, after open-cavity mastoidectomy surgery, after the accumulation of epithelial debris in the external auditory canal, and after the use of hearing aids with an occlusive ear mould [36,78]. Many factors encourage infection and changes in the epithelial covering. High humidity creates perfect conditions for fungi growth [38]. The other predisposing factors are dermatological diseases such as dermatophytosis, the loss of cerumen, and the use of topical broad-spectrum antibiotics [14].
The predominant fungal pathogens in otomycosis are different in various literature reports (Table 3). They include Aspergillus flavus [79] (Figure 2), Aspergillus niger, Aspergillus fumigatus, Aspergillus versicolor, Aspergillus candidus, and Aspergillus persii [17].
In a study conducted in Egypt, the majority of fungal otitis cases were related to Aspergillus (84.8% of cases) [80]; furthermore, Aspergillus is considered to be the most prevalent otomycosis agent in India and China [81,82].
In chronic otitis media, different isolates of Aspergillus species are described (Aspergillus niger, Aspergillus flavus, Aspergillus fumigatus, Aspergillus terreus) [83,84]. Most patients suffer from complaints of pruritus, otorrhea, otalgia, tinnitus, and blocking sensation [85,86].
Otoscopy may reveal variable black, green, or grey fluffy elements in the ear canal when Aspergillus is present.
It is not uncommon for otomycosis to develop in patients following acute bacterial otitis media with otorrhea [71] or with the auditory canal showing oedema, erythema, or exfoliation of the epithelium [12].
Since clinical features of otitis are not specific, laboratory diagnosis is essential to define the correct aetiology of otomycosis and to identify effective antifungal therapy, depending on the type of otitis and the fungal pathogen. Certain otomycoses may reveal microscopic images that are highly suggestive of the etiological agent. Microscopy typically shows numerous Aspergillus heads and abundant septate hyphae, in addition to multiple specific fungal structures including microconidia.

4.2. Onychomycosis

Onychomycosis, known as tinea unguium, is a chronic fungal infection of the toenails or fingernails that is usually not painful but can affect a patient’s quality of life by interfering with footwear. The toenails are more frequently involved than fingernails. Onychomycosis may affect up to 30% of the population by age 60 and 70.
It is mostly caused by dermatophytes, and particularly by Trichophyton rubrum [96]. Aspergillus species are the second most frequent agents of non-dermatophytic onychomycosis [97]. Onychomycosis due to Aspergillus species is rare (Figure 3) (Table 4), ranging from 2% to 30% of all cases, and the prevalence is higher among diabetic patients, accounting for almost 71%. [1,15,97].
In addition, it is speculated that Aspergillus strains can have a clear keratinophilic activity, which causes partial or total dystrophy of the affected nails [98]. A review of the relevant literature has shown that there are at least 11 species of Aspergillus which have been found in onychomycoses, either alone or in association with other known pathogens. Such cases usually occur as a result of trauma or colonization [34]. In Malaysia, according to Leelavathi et al. Aspergillus sp. was the main fungus isolated in onychomycosis (59,8%, n = 71), and the mixed cultures of Aspergillus accounted for almost 15,1%. The latter was in combination with fungi such as Penicillium or other non-dermatophytes fungi [99].
Diabetes, peripheral vascular disease, orthopaedic trauma, and advanced age are the most important underlying conditions in onychomycosis due to Aspergillus species, although no risk factors are evident in most of cases [1].
Numerous non-dermatophyte filamentous fungi are usually isolated as commensals from damaged nails, mostly from the toenails of elderly [100]. The toenails are involved more frequently than fingernails due to important exposure to soil, water, and decaying vegetation where Aspergillus moulds flourish [32].
Toenails are more affected by onychomycosis than fingernails, which is probably because of their slow growth and is perhaps encouraged by external factors such as trauma and poor circulation [101].
Dhib et al. included 7151 patients (4709 women and 2442 men) with clinical suspicion of onychomycosis; moulds accounted for 4.2% of cases, and Aspergillus sp was the most frequent one [102].
The clinical characteristics suggesting onychomycosis due to Aspergillus sp are chalky white nail, rapid involvement of lamina, and painful perionyxis without pus [97]. Kara et al. reported onychomycosis due to Aspergillus flavus involving all fingernails and toenails of an immunocompromised patient [103]. In rare cases, physical examination can reveal pronounced dystrophy of the nail plate, onychoclasis, and onychomadesis with black discoloration of the proximal nail bed [100].
To definitely set up a diagnosis of aspergillosis of the nails, one should not depend fully on the clinical signs, which by themselves may be confusing.

4.3. Cutaneous aspergillosis

Cutaneous diseases of multiples aetiologies are commonly encountered in human clinical practice; cutaneous aspergillosis is usually a skin presentation of disseminated infection with the genus Aspergillus. Initial cutaneous disease is infrequent and is most commonly caused by Aspergillus fumigatus, Aspergillus flavus, Aspergillus terreus, and Aspergillus ustus.
Primary cutaneous aspergillosis occurs in the sites of direct skin lesion or injury following surgery, burns, trauma, occlusive dressing, or intravenous cannulation [3,26]. It can also happen directly in the surgical wound among renal or liver transplantation patients [13,61,66]. On the other hand, primary cutaneous aspergillosis should be suspected in the significantly low birth weight population with fast progressive ulcerating and necrotic skin lesions [3].
Secondary cutaneous aspergillosis spreads through hematogenous dissemination to the skin from a distant point. Usually, it follows the inaugural pulmonary infection [43,46,51,58,72].
There is a third route by which Aspergillus arrives at the skin or mucosa from a neighbouring cavity, for example, paranasal or maxillary sinuses.
Cases of cheek, nose, and eyelid necrotic ulcers following rhinosinusitis have also been reported [12]. Moreover, cutaneous infections have been described in neonates, in immunosuppressed children, and after traumatic injuries, with varying treatment options [49,57,113]. For an instance, skin infections due to A. terreus are particularly rare [114]. Although most of these patients had leukaemia, the literature has reported other diseases, including astrocytoma [55], aplastic anaemia [46,54,55], chronic granulomatous disease [115], and agranulocytosis managed with antithymocyte globulin [50,51,61,116]. Cutaneous aspergillosis reports in immunocompromised patients are depicted in Table 5.
Aspergillosis affects 0.4–7% of hospitalized patients with burn injuries [70]. Cutaneous aspergillosis in burn patients is well described; it is not automatically related to immunosuppression [6,10,43,44]. Fungal wound infection has a high rate of mortality, especially by aspergillosis, which is around 87.1% [117]. For an instance, in an immunocompetent patient without medical history, severe fungal wound infection was related to Aspergillus tamarii [118].
However, all superficial and cutaneous lesions cannot be attributed to environmental Aspergillus that can usually colonize skin and upper respiratory tract; therefore, additional risk factors are needed to trigger an Aspergillus infection.

5. Conclusions

Aspergillus species are ubiquitous and saprophytic; they can cause a category of superficial and cutaneous mycoses: onychomycosis, otomycosis, and skin aspergillosis. This group of diseases caused by Aspergillus genus is relatively rare and poorly described.
Colonization is the initial step in aspergillosis. Fungal conidia can develop and grow on a damaged skin or after inhalation. Risk factors are various and they include: (a) environmental factors, such as climate, outdoor and hospital conditions and (b) host factors, including occupational exposure (agriculture exposure), increased local humidity and skin maceration, trauma exposure (self-induced trauma, skin injuries, burns, orthopaedic trauma), underlying medical conditions (HIV, diabetes mellitus, cancer, transplant recipients), and medical procedures (instrumentation, medical devices, catheters, bandages, drugs).
The main causative agent of otomycosis is Aspergillus niger. Mould onychomycosis is dominated by Aspergillus flavus, and cutaneous aspergillosis is caused principally by Aspergillus fumigatus.
Otomycosis and onychomycosis are very common diseases. Due to the incapacity of an effective keratolysis, Aspergillus growth needs a fragilized keratin (ablution, humidity). In this clinical group of superficial aspergilloses, immunosuppression can cause more severe and aggressive forms of otomycosis and onychomycosis.
On the other hand, the cutaneous Aspergillus entity is seen more in immunocompromised patients, especially after catheter insertion or medical procedure; otherwise, trauma and burn can also predispose to cutaneous Aspergillus.
The treatment of cutaneous and superficial aspergillosis is based on antifungal drugs (itraconazole, amphotericin B). Surgical debridement can be required, especially in the cutaneous, ulcerative, or necrotic forms (burn patients). However, aspergillosis is relatively recurrent and difficult to treat. Thus, patient education regarding predisposing factors is necessary, as highlighted in this paper.

Author Contributions

Conceptualization, writing: Y.M. Review, editing: Y.M., H.D., Z.B. and M.B. All authors have read and agreed to the published version of the manuscript.

Funding

Not applicable.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Written patient consent was obtained from patients for the photos included in this review.

Data Availability Statement

No new data were created or analysed in this study. Data sharing is not applicable to this article.

Acknowledgments

I would like to thank Haiet Adjmi-Hamoudi for advice and orientations.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Noguchi, H.; Hiruma, M.; Miyashita, A.; Makino, K.; Miyata, K.; Ihn, H. A Case of Fingernail Onychomycosis due to Aspergillus flavus. Med. Mycol. J. 2016, 57, e21–e25. [Google Scholar] [CrossRef]
  2. Romero, L.S.; Hunt, S.J. Hickman catheter-associated primary cutaneous aspergillosis in a patient with the acquired immunodeficiency syndrome. Int. J. Dermatol. 1995, 34, 551–553. [Google Scholar] [CrossRef] [PubMed]
  3. Rogdo, B.; Kahlert, C.; Diener, P.A.; Micallef, J. Primary cutaneous aspergillosis in a preterm neonate. BMJ Case Rep. 2014, 2014, 2014204752. [Google Scholar] [CrossRef]
  4. Shetty, D.; Giri, N.; Gonzalez, C.E.; Pizzo, P.A.; Walsh, T.J. Invasive aspergillosis in human immunodeficiency virus-infected children. Pediatr. Infect. Dis. J. 1997, 16, 216–221. [Google Scholar] [CrossRef]
  5. Iwen, P.C.; Rupp, M.E.; Langnas, A.N.; Reed, E.C.; Hinrichs, S.H. Invasive Pulmonary Aspergillosis Due toAspergillus terreus: 12-Year Experience and Review of the Literature. Clin. Infect. Dis. 1998, 26, 1092–1097. [Google Scholar] [CrossRef] [Green Version]
  6. Anh-Tram, Q. Infection of burn wound by Aspergillus fumigatus with gross appearance of fungal colonies. Med. Mycol. Case Rep. 2019, 24, 30–32. [Google Scholar]
  7. Merad, Y.; Adjmi-Hamoudi, H. Self-injury in schizophrenia as predisposing factor for otomycoses. Med. Mycol. Case Rep. 2018, 21, 52–53. [Google Scholar]
  8. Tahir, C.; Garbati, M.; Nggada, H.A.; Terna Yawe, E.H.; Auwal, A.M. Primary Cutaneous Aspergillosis in an Immunocompetent Patient. J. Surg. Tech. Case Rep. 2011, 3. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Googe, P.B.; Decoste, S.D.; Herold, W.H.; Mihm, M.C. Primary cutaneous aspergillosis mimicking dermatophytosis. Arch. Pathol. Lab. Med. 1989, 113, 1284–1286. [Google Scholar] [PubMed]
  10. Moussa, H.; Al-Bader, S.; Hassan, D. Correlation between fungi isolated from burn wound and burn care unit. Burns 1999, 25, 1457. [Google Scholar] [CrossRef]
  11. Anderson, L.L.; Giandoni, M.B.; Keller, R.A.; Grabski, W.J. Surgical wound healing complicated by Aspergillus infection in a non immunocompromised host. Dermatol. Surg. 1995, 21, 799–801. [Google Scholar] [CrossRef] [PubMed]
  12. Pasqualotto, A. Aspergillosis: From Diagnosis to Prevention; Springer: Berlin/Heidelberg, Germany, 2010; p. 1000. [Google Scholar]
  13. Langlois, R.P.; Flegel, K.M.; Meakins, J.L.; Morehouse, D.D.; Robson, H.G.; Guttmann, R.D. Cutaneous aspergillosis with fatal dissemination in a renal transplant recipient. Can. Med. Assoc. J. 1980, 122, 673–676. [Google Scholar]
  14. Chander, J.; Maini, S.; Subrahmanyan, S.; Handa, A. Otomycosis—A clinico-mycological study and efficacy of mercurochrome in its treatment. Mycopathologia 1996, 135, 9–12. [Google Scholar] [CrossRef]
  15. Bongomin, F.; Batac, C.R.; Richardson, M.D.; Denning, D.W. A Review of Onychomycosis Due to Aspergillus Species. Mycopathologia 2017, 183, 485–493. [Google Scholar] [CrossRef] [Green Version]
  16. Beaney, G.P.E.; Broughton, A. Tropical Otomycosis. J. Laryngol. Otol. 1967, 81, 987–997. [Google Scholar] [CrossRef]
  17. Merad, Y.; Adjmi-Hamoudi, H.; Merad, F.Z.S.; Djeriou, S. Otomycosis in the fisherman community: A survey at Bénisaf harbour, Aïn Témouchent, Algeria. J. Med. Biomed. Appl. Sci. 2018, 6, 118–120. [Google Scholar]
  18. Summerbel, R.C.; Kane, J.; Krajden, S. Onychomycosis, tinea pedis and tinea manuum Caused by non-dermatophytic fil- amentous fungi nicht-dermatophyten-fadenpilze als erreger von onychomykosen. Tinea pedis und Tinea manuum. Mycoses 1989, 32, 609–619. [Google Scholar] [CrossRef]
  19. Sehulster, L.; Chinn, R.Y.; CDC; HICPAC. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm. Rep. 2003, 52, 1–42. [Google Scholar] [PubMed]
  20. Perfect, J.R.; Cox, G.M.; Lee, J.Y.; Kauffman, C.A.; De Repentigny, L.; Chapman, S.W.; Morrison, V.A.; Pappas, P.; Hiemenz, J.W.; Stevens, D.A.; et al. The Impact of Culture Isolation ofAspergillusSpecies: A Hospital-Based Survey of Aspergillosis. Clin. Infect. Dis. 2001, 33, 1824–1833. [Google Scholar] [CrossRef] [Green Version]
  21. Pfaller, M.A.; Pappas, P.G.; Wingard, J.R. Invasive Fungal Pathogens: Current Epidemiological Trends. Clin. Infect. Dis. 2006, 43 (Suppl. S1), S3–S14. [Google Scholar] [CrossRef]
  22. Marr, K.A.; Carter, R.A.; Crippa, F.; Wald, A.; Corey, L. Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients. Clin. Infect. Dis. 2002, 34, 909–917. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Gupta, A.K.; Cooper, E.A.; Macdonald, P.; Summerbell, R.C. Utility of Inoculum Counting (Walshe and English Criteria) in Clinical Diagnosis of Onychomycosis Caused by Nondermatophytic Filamentous Fungi. J. Clin. Microbiol. 2001, 39, 2115–2121. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Papini, M.; Piraccini, B.M.; Difonzo, E.; Brunoro, A. Epidemiology of onychomycosis in Italy: Prevalence data and risk factor identification. Mycoses 2015, 58, 659–664. [Google Scholar] [CrossRef]
  25. Tosti, A.; Piraccini, B.M. Correspondence. Proximal subungual onychomycosis due to Aspergillus niger: Report of two cases. Br. J. Dermatol. 1998, 139, 156–157. [Google Scholar] [CrossRef] [PubMed]
  26. Torrelo, A.; Hernández-Martín, A.; Scaglione, C.; Madero, L.; Colmenero, I.; Zambrano, A. Primary Cutaneous Aspergillosis in a Leukemic Child. Actas Dermosifilogr. 2007, 98, 276–278. [Google Scholar] [CrossRef]
  27. Woodruff, C.A.; Hebert, A.A. Neonatal primary cutaneous aspergillosis: Case report and review of the literature. Pediatr. Dermatol. 2002, 19, 439–444. [Google Scholar] [CrossRef]
  28. Gupta, M.; Weinberger, B.; Whitley-Williams, P.N. Cutaneous aspergillosis in a neonate. Pediatr. Infect. Dis. J. 1996, 15, 464–465. [Google Scholar] [CrossRef]
  29. Papouli, M.; Roilides, E.; Bibashi, E.; Andreou, A. Primary Cutaneous Aspergillosis in Neonates: Case Report and Review. Clin. Infect. Dis. 1996, 22, 1102–1104. [Google Scholar] [CrossRef] [Green Version]
  30. Kim, D.M.; Suh, M.K.; Ha, G.Y.; Sohng, S.H. Fingernail Onychomycosis Due toAspergillus niger. Ann. Dermatol. 2012, 24, 459–463. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  31. Merad, Y.; Moulay, A.A.; Derrar, H.; Belkacemi, M.; Larbi-Cherak, N.A.; Ramdani, F.Z.; Belmokhtar, Z.; Messafeur, A.; Drici, A.; Ghomari, O.; et al. Aspergillus flavus onychomycosis in the right fourth fingernail related to phalynx fracture and traumatic inoculation of plants: A vegetable vendor case report. Am. Res. J. Dermatol. 2020, 2, 1–4. [Google Scholar]
  32. Banu, A.; Anand, M.; Eswari, L. A rare case of onychomycosis in all 10 fingers of an immunocompetent patient. Indian Dermatol. Online J. 2013, 4, 302–304. [Google Scholar] [CrossRef]
  33. Nascimento, M.D.D.S.B.; Leitão, V.M.S.; Neto, M.A.C.D.S.; Maciel, L.B.; Filho, W.E.M.; Viana, G.M.D.C.; Bezerra, G.F.D.B.; Da Silva, M.A.C.N. Eco-epidemiologic study of emerging fungi related to the work of babacu coconut breakers in the State of Maranhao, Brazil. Rev. Soc. Bras. Med. Trop. 2014, 47, 74–78. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Ozer, B.; Kalaci, A.; Duran, N.; Dogramaci, Y.; Yanat, A.N. Cutaneous infection caused by Aspergillus terreus. J. Med. Microbiol. 2009, 58, 968–970. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Wang, M.-C.; Liu, C.-Y.; Shiao, A.-S.; Wang, T. Ear Problems in Swimmers. J. Chin. Med. Assoc. 2005, 68, 347–352. [Google Scholar] [CrossRef] [Green Version]
  36. Zaror, L.; Fischma, O.; Suzuki, F. Otomycosis in Sao Paulo. Rev. Inst. Med. Trop. Sao Paulo 1991, 33, 169–173. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Opperman, C.J.; Copelyn, J. Aspergillus niger otomycosis in a child with chronic otitis externa. South. Afr. J. Infect. Dis. 2020, 35, 128. [Google Scholar] [CrossRef]
  38. Khan, A.; Kumar Jain, S. Fungal Otomycosis in Swimmers. Int. J. Life Sci. Bioeng. 2019, 6, 1–8. [Google Scholar]
  39. Dieng, T.; Sow, D.; Tine, R.C.; Yatassaye, F.; Dia, M.; Sylla, K.; Lelo, S.; Dieng, Y. Otomycocis at Fann Hospital in Dakar (Senegal: Prevalence and mycological study. J. Mycol. Mycol. Sci. 2020, 3, 000129. [Google Scholar]
  40. Rifai, N. Clinical Microbiology Elsevier eBook on VitalSource; Elsevier Health Sciences: Amsterdam, The Netherlands, 2019; 200p. [Google Scholar]
  41. Vitrat-Hincky, V.; Lebeau, B.; Bozonnet, E.; Falcon, D.; Pradel, P.; Faure, O.; Aubert, A.; Piolat, C.; Grillot, R.; Pelloux, H. Severe filamentous fungal infections after widespread tissue damage due to traumatic injury: Six cases and review of literature. Scand. J. Infect. Dis. 2009, 41, 491–500. [Google Scholar] [CrossRef]
  42. Panke, T.W.; McManus, A.T.J.; McLeod, C.G.J. “Fruiting bodies” of Aspergillus on thee skin of a burned patient. Am. J. Clin. Pathol. 1978, 69, 188–189. [Google Scholar] [CrossRef]
  43. Becker, W.K.; Cioffi, W.G.; McManus, A.T.; Kim, S.H.; McManus, W.F.; Mason, A.D.; Pruitt, B.A. Fungal burn wound infection: A 10-year experience. Arch. Surg. 1991, 126, 44–48. [Google Scholar] [CrossRef] [PubMed]
  44. Schaal, J.; Leclerc, T.; Soler, C.; Donat, N.; Cirrode, A.; Jault, P.; Bargues, L. Epidemiology of filamentous fungal infections in burned patients: A French retrospective study. Burns 2015, 41, 853–863. [Google Scholar] [CrossRef]
  45. Klein, L.; Havel, E.; Smejkal, K.; Cerman, J.; Hošek, F.; Hronek, M. Multiple mechanical and thermal blast injury in civilian industrial setting—Possible parallel to the battlefield blast syndrome type injuries. Mil. Med. Sci. Lett. 2011, 80, 150–158. [Google Scholar] [CrossRef]
  46. Lucas, G.M.; Tucker, P.; Merz, W.G. Primary cutaneous Aspergillus nidulans infection assaociated with a Hickman catheter in a patient with neutropenia. Clin. Infect. Dis. 1999, 29, 1594. [Google Scholar] [CrossRef]
  47. Girmenia, C.; Gastaldi, R.; Martino, P. Catheter-related cutaneous aspergillosis complicated by fungemia and fatal pulmonary infection in an HIV-positive patient with acute lymphocytic leukemia. Eur. J. Clin. Microbiol. Infect. Dis. 1995, 14, 524–526. [Google Scholar] [CrossRef] [PubMed]
  48. Hunt, S.J.C.; Nagi, K.G.; Gross, D.; Wong, D.S.; Mathews, W.C. Primary cutaneous aspergillosis near central venous catheters in patients with the acquired immunodeficiency syndrome. Arch. Dermatol. 1992, 128, 1229–1232. [Google Scholar] [CrossRef]
  49. Allo, M.D.; Miller, J.; Townsend, T.; Tan, C. Primary cutaneous aspergillosis associated with Hickman intravenous catheters. N. Engl. J. Med. 1987, 317, 1105–1108. [Google Scholar] [CrossRef] [Green Version]
  50. Van Burik, J.-A.; Colven, R.; Spach, D.H. Itraconazole treatment for primary cutaneous aspergillosis in patients with AIDS. Clin. Infect. Dis. 1998, 27, 643–644. [Google Scholar] [CrossRef] [Green Version]
  51. Van Burik, J.-A.; Colven, R.; Spach, D.H. Cutaneous Aspergillosis. J. Clin. Microbiol. 1998, 36, 3115–3121. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Choudhary, V.S.; Koley, S.; Mallick, S.; Bose, S.; Basak, S. Proximal subungual onychomycosis caused by Aspergillus flavus in a HIV-positive patient. Indian J. Dermatol. Venerol. Leprol. 2009, 75, 410–412. [Google Scholar] [CrossRef]
  53. Carlile, J.R.; Millet, R.E.; Cho, C.T.; Vats, T.S. Primary Cutaneous Aspergillosis in a Leukemic Child. Arch. Dermatol. 1978, 114, 78–80. [Google Scholar] [CrossRef]
  54. Prystowsky, S.D.; Vogelstein, B.; Ettinger, D.S.; Merz, W.G.; Kaizer, H.; Sulica, V.I.; Zinkham, W.H. Invasive aspergillosis. N. Engl. J. Med. 1976, 295, 655–658. [Google Scholar] [CrossRef] [PubMed]
  55. Weingarten, J.S.; Crockett, D.M.; Lusk, R.P.; Levine, P.A. Fulminant Aspergillosis: Early Cutaneous Manifestations and the Disease Process in the Immunocompromised Host. Otolaryngol. Head Neck Surg. 1987, 97, 495–499. [Google Scholar] [CrossRef] [PubMed]
  56. Mccarty, J.M.; Flam, M.S.; Pullen, G.; Jones, R.; Kassel, S.H. Outbreak of primary cutaneous aspergillosis related to intravenous arm boards. J. Pediatr. 1986, 108, 721–724. [Google Scholar] [CrossRef]
  57. Richards, K.A.; Mancini, A.J. A painful erythematous forearm nodule in a girl with Hodgkin disease. Diagnosis: Primary cutaneous aspergillosis. Arch. Dermatol. 2000, 136, 1165–1170. [Google Scholar] [CrossRef] [PubMed]
  58. Bretagne, S.; Bart-Delabesse, E.; Wechsler, J.; Kuentz, M.; Dhedin, N.; Cordonnier, C. Fatal primary cutaneous aspergillosis in a bone marrow transplant recipient: Nosocomial acquisition in a laminar-air flow room. J. Hosp. Infect. 1997, 36, 235–239. [Google Scholar] [CrossRef]
  59. Johnson, E.M.; Borman, A.M. Identification of Aspergillus at the species level the importance of conventional Methods: Microscopy and culture. In Aspergillosis: From Diagnosis to Prevention; Pasqualotto, A.C., Ed.; Springer Science + Business: Berlin/Heidelberg, Germany, 2009. [Google Scholar]
  60. Krishnan, G.; Vadala, R.; Princess, I.; Ebenezer, R. Burns in Diabetes Mellitus Patients among Indian Population: Does it Differ from the Rest? Indian J. Crit. Care Med. 2020, 24, 11–16. [Google Scholar] [CrossRef] [PubMed]
  61. Nampoory, M.; Khan, Z.; Johny, K.; Constandi, J.; Gupta, R.; Al-Muzairi, I.; Samhan, M.; Mozavi, M.; Chugh, T. Invasive fungal infections in renal transplant recipients. J. Infect. 1996, 33, 95–101. [Google Scholar] [CrossRef]
  62. Mert, D.; Iskender, G.; Duygu, F.; Merdin, A.; Dal, M.S.; Dogan, M.; Tekgunduz, E.; Ertek, M.; Altuntas, F. Invasive aspergillosis with dessiminated skin involvement in a patient with acute myeloid leukemia: A rare case. Hematol. Rep. 2017, 9, 6997. [Google Scholar] [CrossRef] [Green Version]
  63. Fuji, S.; Löffler, J.; Savani, B.N.; Einsele, H.; Kapp, M. Hyperglycemia as a possible risk factor for mold infections—the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2016, 52, 657–662. [Google Scholar] [CrossRef] [Green Version]
  64. Fernando, S.S.N.; Wijesuriya, T.M.; Kottahachchi, J.; Gunasekara, T.D.C.P.; Bulugahapitiya, U.; Ranasinghe, K.N.P.; Weerasekara, M.M. Aspergillus species: An emerging pathogen in onychomycosis among diabetics. Indian J. Endocrinol. Metab. 2015, 19, 811–816. [Google Scholar] [CrossRef]
  65. Stiller, M.J.; Teperman, L.; Rosenthal, S.A.; Riordan, A.; Potter, J.; Shupack, J.L.; Gordon, M.A. Primary cutaneous infection by Aspergil- lus ustus in a 62-year-old liver transplant recipient. J. Am. Acad. Dermatol. 1994, 31, 344–347. [Google Scholar] [CrossRef]
  66. Plá, M.P.; Berenguer, J.; Arzuaga, J.A.; Bañares, R.; Polo, J.R.; Bouza, E. Surgical wound infection by Aspergillus fumigatus in liver transplant recipients. Diagn. Microbiol. Infect. Dis. 1992, 15, 703–706. [Google Scholar] [CrossRef]
  67. Greenbaum, R.S.; Roth, J.S.; Grossman, M.E. Subcutaneous nodule in a cardiac transplant. Cutaneous aspergillosis. Arch. Dermatol. 1993, 129, 1191. [Google Scholar] [CrossRef]
  68. Wong, J.; McCracken, G.; Ronan, S.; Aronson, I. Coexistent cutaneous Aspergillus and cytomegalovirus infection in a liver transplant recipient. J. Am. Acad. Dermatol. 2001, 44, 370–372. [Google Scholar] [CrossRef]
  69. Smith, W.F.; Wallace, M.R. Cutaneous aspergillosis. Cutis 1997, 59, 138–140. [Google Scholar] [PubMed]
  70. Ballard, J.; Edelman, L.; Saffle, J.; Sheridan, R.; Kagan, R.; Bracco, D.; Cancio, L.; Cairns, B.; Multicenter Trials Group; American Burn Association; et al. Positive fungal cultures in burn patients: A multicenter review. J. Burn Care Res. 2008, 29, 213–221. [Google Scholar] [CrossRef] [PubMed]
  71. Anwar, K.; Gohar, M.S. Otomycosis; clinical features, predisposing factors and treatment implications. Pak. J. Med. Sci. 2014, 30, 564–567. [Google Scholar]
  72. Bryce, E.A.; Walker, M.; Scharf, S.; Lim, A.T.; Walsh, A.; Sharp, N.; Smith, J.A. An outbreak of cutaneus aspergillosis in tertiary-care hospital. Infect. Control Hosp. Epidemiol. 1996, 17, 170–172. [Google Scholar] [CrossRef]
  73. Gallais, F.; Denis, J.; Koobar, O.; Dillenseger, L.; Astruc, D.; Herbrecht, R.; Candolfi, E.; Letscher-Bru, V.; Sabou, M. Simultaneous primary invasive in two preterm twins: Case report and review of the literature. BMC Infect. Dis. 2017, 17, 535. [Google Scholar] [CrossRef] [Green Version]
  74. Kusari, A.; Sprague, J.; Eichenfield, L.F.; Matiz, C.; Barrio, V.R. Primary cutaneous aspergillosis at the site of cyanoacrylate skin adhesive in a neonate. Pediatr. Dermatol. 2018, 35, 494–497. [Google Scholar] [CrossRef]
  75. Schrader, N.; Isaacson, G. Fungal otitis externa--its association with fluoroquinolone eardrops. Pediatrics 2003, 111, 1123. [Google Scholar] [CrossRef]
  76. Rutt, A.L.; Sataloff, R.T. Aspergillus otomycoses in an immunocompromised. ENT Ear Throat J. 2008, 87, N11. [Google Scholar]
  77. Parize, P.; Chandesris, M.-O.; Lanternier, F.; Poirée, S.; Viard, J.-P.; Bienvenu, B.; Mimoun, M.; Méchai, F.; Mamzer, M.-F.; Herman, P.; et al. Antifungal Therapy of Aspergillus Invasive Otitis Externa: Efficacy of Voriconazole and Review. Antimicrob. Agents Chemother. 2008, 53, 1048–1053. [Google Scholar] [CrossRef] [Green Version]
  78. Deshmukh, J.; Surpam, R.; Band, A. Mycological study of aspergillus infections in otomycosis in eastern part of maharashtra. Int. J. Health Sci. Res. 2014, 4, 77–82. [Google Scholar]
  79. Barati, B.; Okhovvat, S.A.R.; Goljanian, A.; Omrani, M.R. Otomycosis in Central Iran: A Clinical and Mycological Study. Iran. Red Crescent Med. J. 2011, 13, 873–876. [Google Scholar] [PubMed]
  80. Moharram, A.M.; Ahmed, H.E.; Nasr, S.A.M. Otomycosis in Assiut, Egypt. J. Basic Appl. Mycol. 2013, 4, 1–11. [Google Scholar]
  81. Jia, X.; Liang, Q.; Chi, F.; Cao, W. Otomycosis in Shanghai: Aetiology, clinical features and therapy. Mycoses 2012, 55, 404–409. [Google Scholar] [CrossRef]
  82. Aneja, K.R.; Sharma, C.; Joshi, R. Fungal infection of the ear; a common problem in the north eastern part of Hayana. Int. J. Pediatr. Otorhinolaryngol. 2010, 74, 604–607. [Google Scholar] [CrossRef] [PubMed]
  83. Ghosh, A.; Rana, A.; Prasad, S. Prevalence of Fungal Infection in Chronic Suppurative Otitis Media-A Study at Tertiary Care Hospital in Western Uttar Pradesh. Indian J. Microbiol. Res. 2015, 2, 159. [Google Scholar] [CrossRef]
  84. Rachna, D.; Shamin, M.; Mandeep, K.; Rajendra, S.B.; Rupali, H.A. Role of Fungal infections in CSOM—Prospective study. Indian J. Basic Appl. Med. Res. 2014, 3, 598–608. [Google Scholar]
  85. Loh, K.S.; Tan, K.K.; Kumarasinghe, G.; Leong, H.K.; Yeoh, K.H. Otitis externa--the clinical pattern in a tertiary institution in Singapore. Ann. Acad. Med. Singap. 1998, 27, 215–218. [Google Scholar] [PubMed]
  86. Pontes, Z.B.V.D.S.; Silva, A.D.F.; Lima, E.D.O.; Guerra, M.D.H.; Oliveira, N.M.C.; Carvalho, M.D.F.F.P.; Guerra, F.S.Q. Otomycosis: A retrospective study. Braz. J. Otorhinolaryngol. 2009, 75, 367–370. [Google Scholar] [CrossRef] [PubMed]
  87. Garcia-Agudo, L.; Aznar-Marin, P.; Galan-Sanchez, F.; Garcia-Martos, P.; Marin-Casanova, P.; Rodriguez-Iglesias, M. Otomycosis due to Filamentous Fungi. Mycopathologia 2011, 172, 307–310. [Google Scholar] [CrossRef] [PubMed]
  88. Araiza, J.; Canseco, P.; Bonifaz, A. Otomycosis: Clinical and mycological study of 97 cases. Rev. Laryngol. Otol. Rhinol. 2006, 127, 251–254. [Google Scholar]
  89. Saki, N.; Nikakhlagh, S.; Rafiei, A.; Amirrajab, N. P239 Prevalence of fungal agents of otomycosis in Ahwaz, Iran. Int. J. Antimicrob. Agents 2009, 34, S102. [Google Scholar] [CrossRef]
  90. Desai, K.J.; Malek, S.S.; Italia, I.K.; Jha, S.; Pandya, V.; Shah, H. Fungal Spectrum in Otomycosis at Tertiary Care Hospital. NJIRM 2012, 3, 58–61. [Google Scholar]
  91. Satish, H.S.; Viswanatha, B.; Manjuladevi, M. A Clinical Study of Otomycosis. IOSR 2013, 5, 57–62. [Google Scholar] [CrossRef]
  92. Fayemiwo, S.A.; Ogunleye, O.; Adeosun, A.A.; Barake, R.A. Prevalence of otomycoses in Ibadan: A review of laboratory reports. Afr. J. Med. Sci. 2010, 39, 219–222. [Google Scholar]
  93. Yavo, W.; Kassi, R.R.; Kiki-Barro, P.C.; Bamba, A.; Kplé, T.; Menan, E.I.H.; Ehouo, F.; Koné, M. Prévalence et facteurs favorisants des otomycoses traitées en milieu hospitalier à Abidjan. Côted’Ivoire Med. Trop. 2004, 64, 39–42. [Google Scholar]
  94. Al-Abbasi, A.M.; Al-Sadoon, A.; Sabbar, B.A. Otomycosis in Basrah, Iraq. J. Arab Board Health Spec. 2011, 12, 28–33. [Google Scholar]
  95. Bassiouny, A.; Kamel, T.; Moawed, M.K.; Hindawy, D.S. Broad spectrum antifungal agents in otomycosis. J. Laryngol. Otol. 1986, 100, 867–873. [Google Scholar] [CrossRef]
  96. Zaias, N.; Escovar, S.; Rebell, G. Opportunistic toenail onychomycosis. The fungal colonization of an available nail unit space by non-dermatophytes is produced by the trauma of the closed shoe by an asymmetric gait or other trauma. A plausible theory. J. Eur. Acad. Dermatol. Venereol. 2014, 28, 1002–1006. [Google Scholar] [CrossRef]
  97. Gianni, C.; Romano, C. Clinical and Histological Aspects of Toenail Onychomycosis Caused by Aspergillus spp.: 34 Cases Treated with Weekly Intermittent Terbinafine. Dermatology 2004, 209, 104–110. [Google Scholar] [CrossRef] [PubMed]
  98. Gugnani, H.C.; Vijayan, V.K.; Tyagi, P.; Sharma, S.; Stchigel, A.M.; Guarro, J. Onychomycosis due to Emericella quadrilineata. J. Clin. Microbiol. 2004, 42, 914–916. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  99. Leelavathi, M.; Tzar, M.N.; Adawiah, J. Common Microorganisms Causing Onychomycosis in Tropical Climate. Sains Malays. 2012, 41, 697–700. [Google Scholar]
  100. Alvarez, M.I.; González, L.A.; Castro, L.A. Onychomycosis in Cali, Colombia. Mycopathologia 2004, 158, 181–186. [Google Scholar] [CrossRef]
  101. Hay, R. Literature review. Onychomycosis. J. Eur. Acad. Dermatol. Venereol. 2005, 19 (Suppl. S1), 1–7. [Google Scholar] [CrossRef] [PubMed]
  102. Dhib, I.; Fathallah, A.; Yaacoub, A.; Zemni, R.; Gaha, R.; Said, M.B. Clinical and mycological features of onychomycosis in central Tunisia: A 22 years retrospective study (1986–2007). Mycoses 2012, 56, 273–280. [Google Scholar] [CrossRef]
  103. Kara, Y.A.; Erdogan, F.G.; Cologlu, D.; Moghtaderi, A.; Dehghan, F.; Mousavizadeh, A.; Khakpour, N. A Case of Onychomycosis due to Aspergillus flavus in all Fingernails and Toenails of an Immunocompromised Patient. J. Clin. Exp. Dermatol. Res. 2017, 9, 1–4. [Google Scholar] [CrossRef]
  104. Hirose, M.; Noguchi, H.; Yaguchi, T.; Matsumoto, T.; Hiruma, M.; Fukushima, S.; Ihn, H. Onychomycosis caused by Aspergillus subramanianii. J. Dermatol. 2018, 45, 1362–1366. [Google Scholar] [CrossRef]
  105. Moubasher, A.; Abdel-Sater, M.; Soliman, Z. Incidence and biodiversity of yeasts, dermatophytes and non-dermatophytes in superficial skin infections in Assiut, Egypt. J. Mycol. Méd. 2017, 27, 166–179. [Google Scholar] [CrossRef]
  106. Motamedi, M.; Ghasemi, Z.; Shidfar, M.R.; Hosseinpour, L.; Khodadadi, H.; Zomorodian, K.; Mirhendi, H. Growing Incidence of Non-Dermatophyte Onychomycosis in Tehran, Iran. Jundishapur J. Microbiol. 2016, 9, e40543. [Google Scholar] [CrossRef] [Green Version]
  107. Sharma, D.; Capoor, M.R.; Ramesh, V.; Gupta, S.; Shivaprakash, M.R.; Chakrabarti, A. A rare case of onychomycosis caused by Emericella quadrilineata (Aspergillus tetrazonus). Indian J. Med Microbiol. 2015, 33, 314–316. [Google Scholar] [CrossRef] [PubMed]
  108. Zotti, M.; Agnoletti, A.F.; Vizzini, A.; Cozzani, E.; Parodi, A. Onychomycosis from Aspergillus melleus, a novel pathogen for humans. Fungal identification and in vitro drug susceptibility. Exp. Dermatol. 2015, 24, 966–968. [Google Scholar] [CrossRef] [PubMed]
  109. Nouripour-Sisakht, S.; Mirhendi, H.; Shidfar, M.; Ahmadi, B.; Rezaei-Matehkolaei, A.; Geramishoar, M.; Zarei, F.; Jalalizand, N. Aspergillus species as emerging causative agents of onychomycosis. J. Mycol. Méd. 2015, 25, 101–107. [Google Scholar] [CrossRef]
  110. Ahmadi, B.; Hashemi, S.J.; Zaini, F.; Shidfar, M.R.; Moazeni, M.; Mousavi, B.; Noorbakhsh, F.; Ghemrishoar, M.; Hossein, L.; Rezaie, S. A case of onychomycosis caused by Aspergillus candidus. Med. Mycol. Case Rep. 2012, 1, 45–48. [Google Scholar] [CrossRef] [PubMed]
  111. Zotti, M.; Machetti, M.; Perotti, M.; Barabino, G.; Persi, A. A new species, Aspergillus persii, as an agent of onychomycosis. Med. Mycol. 2010, 48, 656–660. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  112. Brasch, J.; Varga, J.; Jensen, J.-M.; Egberts, F.; Tintelnot, K. Nail infection by Aspergillus ochraceopetaliformis. Med. Mycol. 2009, 47, 658–662. [Google Scholar] [CrossRef] [Green Version]
  113. Amod, F.C.; Coovadia, Y.M.; Pillay, T.; Ducasse, G. Primary Cutaneous Aspergillosis in Ventilated Neonates. Pediatr. Infect. Dis. J. 2000, 19, 482–483. [Google Scholar] [CrossRef] [PubMed]
  114. Lass-Florl, C.; Griff, K.; Mayr, A.; Petzer, A.; Gastl, G.; Bonatti, H.; Freund, M.; Kropshofer, G.; Dierich, M.P.; Nachbaur, D. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br. J. Haematol. 2005, 131, 201–207. [Google Scholar] [CrossRef] [PubMed]
  115. Dohil, M.A.; Prendiville, J.S.; Crawford, R.I.; Speert, D.P. Cutaneous manifestations of chronic granulomatous disease: A report of four cases and review of the literature. J. Am. Acad. Dermatol. 1997, 36, 899–907. [Google Scholar] [CrossRef]
  116. Neumeister, B.; Hartmann, W.; Oethinger, M.; Heymer, B.; Marre, R. A fatal infection with Alternaria alternata and Aspergillus terreus in a child with agranulocytosis of unknown origin. Mycoses 1994, 37, 181–185. [Google Scholar] [CrossRef]
  117. Ali, M.; Reza, M.; Gholipourmalekabadi, M.; Samadikuchaksaraei, A. The prevalence of fungal infections in a level I Iranian burn hospital. Asian Biomed. 2013, 7, 829–833. [Google Scholar]
  118. Aries, P.; Hoffmann, C.; Schaal, J.-V.; Leclerc, T.; Donat, N.; Cirodde, A.; Masson, Y.; Renner, J.; Soler, C. Aspergillus tamari: Anuncommon burn wound infection. J. Clin. Pathol. 2018, 71, 379–380. [Google Scholar] [CrossRef] [PubMed]
  119. Cooke, F.; Terpos, E.; Boyle, J.; Rahemtulla, A.; Rogers, T. Disseminated Aspergillus terreus infection arising from cutaneous inoculation treated with caspofungin. Clin. Microbiol. Infect. 2003, 9, 1238–1241. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Etiological factors of superficial and cutaneous aspergillosis.
Figure 1. Etiological factors of superficial and cutaneous aspergillosis.
Pathogens 10 00643 g001
Figure 2. (a) Clinical appearance of self-induced otomycosis in a schizophrenic patient; (b) macroscopic aspect of Aspergillus flavus.
Figure 2. (a) Clinical appearance of self-induced otomycosis in a schizophrenic patient; (b) macroscopic aspect of Aspergillus flavus.
Pathogens 10 00643 g002
Figure 3. (a) Aspergillus onychomycosis induced by trauma in a vegetable vendor patient; (b) Aspergillus flavus culture macroscopy.
Figure 3. (a) Aspergillus onychomycosis induced by trauma in a vegetable vendor patient; (b) Aspergillus flavus culture macroscopy.
Pathogens 10 00643 g003
Table 1. Reports of traumatic inoculation of Aspergillus genus.
Table 1. Reports of traumatic inoculation of Aspergillus genus.
Traumatic InoculationLocationContextSpeciesReferences
Self-induced injuryEarSchizophreniaA. flavusMerad et al. 2018 [7]
BurnsSkinBurnsA. fumigatusAnh-Tram et al. 2019 [6]
BurnsAspergillus spSchaal et al. 2015 [44]
Thermal blast injuryAspergillus spKlein et al. 2011 [45]
BurnsAspergillus spMousssa et al. 1999 [10]
BurnsAspergillus spBecker et al. 1991 [42,43]
TraumaSkinShaving axillae and perineumAspergillus spTahir et al. 2011 [8]
Traffic traumaAspergillus spVitrat-Hinky et al. 2009 [41]
Agricultural traumaA. terreusOzer et al. 2000 [34]
8 casesA. flavusIwen et al. 1998 [5]
4 casesA. fumigatusIwen et al. 1998 [5]
Trauma wound infection (HIV)A. glaucusShetty et al. 1997 [4]
NailOrthopedic trauma; GardeningA. flavus
A. flavus
Merad et al. 2019 [31]
Naguchi et al. 2016 [1]
Working in agricultural fieldA. nigerBanu et al. 2013 [32]
Coconut breakersAspergillus spNascimento et al. 2014 [33]
Tight shoesNailTight shoesAspergillusRifai et al. 2019 [40]
Medical traumaEarNon-healing surgical woundA. flavusAnderson et al. 1995 [11]
SkinCatheter site infectionAspergillus spLucas et al. 1999 [46]
Girmenia et al. 1995 [47]
Romero et al. 1995 [2]
Hunt et al. 1992 [48]
Allo et al. 1987 [49]
Table 2. Underlying medical conditions related to cutaneous aspergillosis.
Table 2. Underlying medical conditions related to cutaneous aspergillosis.
Underlying Medical ConditionContextLocationSpeciesReferences
HIVHIVProximal nail
Skin
Aspergillus sp
Aspergillus sp
Aspergillus sp
Choudhary et al. 2009 [52]
Romero et al. 1995 [2]
Hunt et al. 1992 [48]
CancerHodgkin disease
Leukemia
Aplastic anemia
Astrocytoma
Chronic granulomatosis
Leukemia
Skin
Skin
Skin
Skin
Skin
Skin
Aspergillus sp
Aspergillus sp
Aspergillus sp
Aspergillus sp
Aspergillus sp
Aspergillus sp
Richards et al. 2000 [57]
Van Burik et al. 1998 [51]
Van Burik et al. 1998 [51]
Allo et al. 1987 [49]
McCarty et al. 1986 [58]
Carlile et al. 1978 [51]
Solid
organ
transplant
recipients
Renal transplantSkinAspergillus sp
Aspergillus sp
Nampoory et al. 1996 [61]
Langlois et al. 1980 [13]
Liver transplantSkinA. ustus
A. fumigatus
Stiller et al. 1994 [65]
Pla et al. 1992 [66]
Cardiac transplantSkinAspergillus spGreenbaum et al. 1993 [67]
Marrow transplantSkinA. niger Aspergillus spJohnson et al. 2009 [59]
Bretagne et al. 1997 [58]
Diabetes mellitusDiabetes mellitusNailAspergillus spWijesuriya et al. 2015 [64]
Cytomegaloviirus InfectionLiver transplant recipientSkinAspergillus spWong et al. 2001 [68]
Liver disease-SkinAspergillus spIwen et al. 1998 [5]
Table 3. Distribution of Aspergillus otomycosis in some countries.
Table 3. Distribution of Aspergillus otomycosis in some countries.
SpeciesCountry%References
Aspergillus nigerSpain
India
Brazil
Mexico
35.9%(n = 390)
39.8% (n = 118)
20% (n = 103)
21% (n = 97)
García-Agudo et al. 2011 [87]
Aneja et al. 2010 [82]
Pontes et al. 2009 [86]
Araiza et al. 2006 [88]
Aspergillus flavusIran
India
Brazil
Mexico
13% (n = 881)
3.3% (n = 100)
10% (n = 103)
21% (n = 97)
Saki et al. 2013 [89]
Desai et al. 2012 [90]
Pontes et al. 2009 [86]
Araiza et al. 2006 [88]
Aspergillus fumigatusIndia
Iran
India
Nigeria
Brazil
Ivory Cost
10% (n = 200)
6.2% (n = 881)
12.9% (n = 118)
5.7% (n = 53)
5%(n = 103)
4.1% (n = 115)
Satish et al. 2013 [91]
Saki et al. 2013 [89]
Aneja et al. 2010 [82]
Fayemiwo et al. 2010 [92]
Pontes et al. 2009 [86]
Yavo et al. 2004 [93]
Aspergillus terreusIrak
Spain
China
Egypt
10.08% (n = 101)
1.6% (n = 390)
5.5% (6 cases)
3.61% (n = 59)
Al-Abbassi et al. 2011 [94]
Garcia-Agudo et al. 2011 [87]
Aneja et al. 2010 [82]
Bassiouny et al. 2010 [95]
Aspergillus nidulansIrak0.84% (n = 101)Al-Abbassi et al. 2011 [94]
Aspergillus candidusSpain7.1% (n = 390)Garcia-Agudo et al. 2011 [87]
Aspergillus versicolorChina0.87% (n = 115)Jia et al. 2012 [81]
Table 4. Aspergillus onychomycosis reported in some countries.
Table 4. Aspergillus onychomycosis reported in some countries.
AuthorsCountrySpeciesTreatmentContext
Merad et al. 2020 [31]AlgeriaA.flavusOral terbinafin 250 mg/day + amorolfine 5% nail lacquer.No underlying disease
Hirose et al. 2018 [104]JapanA.subramanianiiTerbinafine resolution after 6 monthNo underlying disease
Moubasher et al. 2017 [105]EgyptA. niger, A. flavus,
A. terreus
-No underlying disease
Motamedi et al. 2016 [106]IranA. flavus--
Sharma et al. 2015 [107]IndiaA. tetrazonus--
Zotti et al. 2015 [108]ItalyA. melleus--
Wijesuriya et al. 2015 [64]Sri LankaA. niger (76%)-Diabetic population
Nouripour-Sisakht et al. 2015 [109]IranAspergillus sp: 87.8% (135/463)--
Ahmadi et al. 2012 [110]IranA. candidusOral itraconazole 10 weeks (resistance to terbinafine)No underlying disease
Zotti et al. 2010 [111]ItalyA. persiiIn vitro susceptibility to itraconazoleNo underlying disease
Choudhary et al. 2009 [52]IndiaA. flavus-HIV patient
(Proximal onyxis)
Brasch et al. 2009 [112]GermanyA. ochraceopetaliformisOral Terbinafine+
ciclopiroxolamine
No underlying disease
Table 5. Cutaneous aspergillosis reports in immunocompromised patients.
Table 5. Cutaneous aspergillosis reports in immunocompromised patients.
ReferencesCountrySpeciesContextDescription
Mert et al. 2020 [61]Turkey-Invasive aspergillosis in acute myeloid leukemiaBullous and zosteriform lesions
Gallais et al. 2017 [72]FranceA.fumigatusInvasive cutaneous aspergillosis in two preterm twinsYellowish lesions on abdomen
Rogdo et al. 2014 [3]SwitzerlandA.flavusNeonate-
Torrelo et al. 2007 [26]SpainA. flavusLeukemic childVioleceous nodule of 6 cm with necrotic bullae
Lass-Florl et al. 2005 [107]AustriaA. terreus29% of cutaneous involvement in 67 invasive aspergillosis-
Cook et al. 2003 [119]IndiaA. terreusNon-insulin dependent diabetes mellituswith myeloma1 cm necrotic lesion on the right palm
Richards et al. 2000 [56] Hodgkin’s diseasePainful, erythematous forearm nodule
Van Burik et al. 1998 [50]USAA. fumigatusCatheter-tape-associated in HIV patientNodules
Shetty et al. 1997 [4]USAA. glaucusTrauma wound associated in HIV patientUlcer
Smith et al. 1997 [68]USAA. fumigatusCatheter, transparent-tape-associated in HIV patientPruritic, exophytic lesion
Shetty et al. 1997 [4]USAA. fumigatusCatheter-associated in HIV patientNodules
Romero et al. 1995 [2]USAA. fumigatusCatheter-associated in HIV patientVerrucous plaque with micropustules
Girmenia et al. 1995 [46]ItalyA. fumigatusCatheter-associated in HIV patientIndurated erythema
Iwen et al. 1993 [5]USAA. fumigatus
A. flavus
--
Hunt et al. 1992 [47]USAA. fumigatusCatheter-tape-associated in HIV patientUmbilicated papule
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Merad, Y.; Derrar, H.; Belmokhtar, Z.; Belkacemi, M. Aspergillus Genus and Its Various Human Superficial and Cutaneous Features. Pathogens 2021, 10, 643. https://doi.org/10.3390/pathogens10060643

AMA Style

Merad Y, Derrar H, Belmokhtar Z, Belkacemi M. Aspergillus Genus and Its Various Human Superficial and Cutaneous Features. Pathogens. 2021; 10(6):643. https://doi.org/10.3390/pathogens10060643

Chicago/Turabian Style

Merad, Yassine, Hichem Derrar, Zoubir Belmokhtar, and Malika Belkacemi. 2021. "Aspergillus Genus and Its Various Human Superficial and Cutaneous Features" Pathogens 10, no. 6: 643. https://doi.org/10.3390/pathogens10060643

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop